PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Trends Analyst Outlook Journalist POV

40 hedge funds and large institutions have $677M invested in Phathom Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$227M
2
+$114M
3
+$65.5M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$43.6M
5
A
Abingworth
United Kingdom
+$37.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$227M
2
$114M
3
$65.5M
4
$64.4M
5
$43.6M
6
$37.4M
7
$24.5M
8
$20M
9
$19.2M
10
$14M
11
$11.2M
12
$9.88M
13
$6.42M
14
$4.78M
15
$3.9M
16
$3.56M
17
$2.11M
18
$1.1M
19
$772K
20
$721K
21
$512K
22
$450K
23
$439K
24
$416K
25
$302K
1
2